newsfilter
← Latest News
GlobeNewswire·

Evelo Biosciences Announces $79.2 Million Registered Direct Offering of Common Stock

CAMBRIDGE, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (NASDAQ:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced that it has entered into a securities purchase agr